Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 9396
Country/Region: Côte d'Ivoire
Year: 2010
Main Partner: Partnership for Supply Chain Management
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $29,708,000

Since May 2005, SCMS has been the primary procurement agent for PEPFAR-funded commodities in Cote d'Ivoire and the principal provider of technical assistance for the HIV/AIDS commodities supply chain, including for forecasting and management. As the PEPFAR-supported HIV/AIDS care and treatment program scales up, SCMS procures most drugs, lab supplies, and other commodities for PEPFAR implementing partners. As of September 2009, SCMS was procuring drugs and commodities for 49,697 ART patients and 105,530 non-ART HIV patients, with targets of 59,000 ART patients and 134,000 non-ART HIV patients by September 2010. A critical component of SCMS support is strengthening the data-management and leadership capacities of the Ministry of Health (MOH) to enable it to play its national oversight role more effectively. SCMS will ensure that regular, detailed, and concrete commodities data and analyses are available to inform all stakeholders and empower the MOH to make appropriate evidence-based decisions.

During the past three years, SCMS has provided technical assistance to strengthen the institutional capacity of the Public Health Pharmacy (PSP), selected health districts, and HIV/AIDS care and treatment sites to improve the management of drugs and commodities. SCMS has provided ongoing technical and management support to HIV/AIDS supply-chain coordination at the central and district levels.

Following directives from the MOH, all incoming commodities are delivered to the PSP for storage and subsequent distribution to service sites. Following MOH policy to coordinate procurement, and in an effort to improve efficiency of donors, SCMS has followed an approach of integration and complementarity under which more than one donor provides inputs to a given site. The government of Cote d'Ivoire also buys small amounts of commodities with its own funds.

In addition to procuring most HIV/AIDS-related drugs and consumables for PEPFAR CI, SCMS will use FY 2010 funds to continue technical and management assistance in support of the PSP. SCMS will be held accountable for specific performance results and will adjust its operational plan, in consultation with the USG team, the National HIV/AIDS Care and Treatment Program (PNPEC), and the PSP, as needs evolve. SCMS will regularly update national HIV/AIDS commodities forecasts and validate calculations based on use patterns and will provide ongoing analysis of commodities consumption compared to patient treatment data. SCMS will also advise the MOH and partners on current pharmaceutical market developments, USG-approved products and suppliers, and manufacturing capacity as it affects supply to Cote d'Ivoire.

In coordination with the MOH, Global Fund, other key donors, and PEPFAR partners, SCMS will focus on continuing systems-strengthening activities, including quantifications, stock management, warehousing, and distribution processes at the central level, and will support the PSP to develop and disseminate a sustainable decentralization plan. SCMS will strengthen the LMIS by providing technical assistance to assess and enhance existing systems and/or develop new tools to better inform traceability of ARVs and other commodities.

Funding for SCMS is requested in the following budget codes: HXTD, MTXT, HVCT, HBHC, PDCS, HLAB, HVSI, and in three new budget codes, HXTS, PDTX, and OHSS. Overall mechanism funding is decreasing from $32,543,179 in FY 2009 to $29,708,000 in FY 2010, in large part because of lower estimates on needed ARV procurements and SCMS' significant funding pipeline.

Funding for Care: Adult Care and Support (HBHC): $4,845,000

Substantially increased funding for SCMS in the HBHC budget code reflects a shift of lab monitoring procurement costs for non-ART-eligible adult HIV patients from the HLAB to the HBHC budget code. Estimates of other costs are lower than in FY 2009, based in large part on 1) buying cotrimoxazole for 75% of HIV patients (in accordance with national guidelines) instead of 100%, and 2) not buying additional impregnated bed nets, as the Global Fund Malaria Grant is supplying enough bed nets to cover anticipated priority needs.

Funding for Treatment: Adult Treatment (HTXS): $2,680,000

The addition of HTXS funding for SCMS reflects a shift of lab monitoring procurement costs for adult ART patients from HLAB to HTXS.

Funding for Testing: HIV Testing and Counseling (HVCT): $3,757,000

Increased funding for SCMS in the HVCT budget code reflects higher targets and costs for testing (including a more expensive new testing algorithm) at PEPFAR-supported testing and counseling sites.

Funding for Care: Pediatric Care and Support (PDCS): $956,000

Substantially increased funding for SCMS in the PDCS budget code reflects a shift of lab monitoring procurement costs for non-ART-eligible pediatric HIV patients, as well as some procurement costs for early infant diagnosis, from the HLAB to the HBHC budget code.

Funding for Treatment: Pediatric Treatment (PDTX): $233,000

The addition of PDTX funding for SCMS reflects a shift of lab monitoring procurement costs for pediatric ART patients from HLAB to HTXS.

Funding for Strategic Information (HVSI): $610,000

None

Funding for Health Systems Strengthening (OHSS): $400,000

The addition of OHSS funding for SCMS is intended to support training and logistics automation as Côte d'Ivoire decentralizes its Public Health Pharmacy (PSP), including moving logistics officers to the regions. Funding will support in-service training for 25 pharmacists at PSP, 11 regional pharmacists, and 75 health district pharmacist, as well as the renovation of five health district pharmacies and automation of the logistics management information system for ARVs and laboratory commodities.

Funding for Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT): $2,031,000

Increased funding for SCMS in the MTCT budget code reflects higher targets and costs for testing (including a more expensive new testing algorithm) and prophylaxis at PEPFAR-supported PMTCT sites.

Funding for Laboratory Infrastructure (HLAB): $536,000

None

Funding for Treatment: ARV Drugs (HTXD): $13,660,000

None

Cross Cutting Budget Categories and Known Amounts Total: $1,033,472
Construction/Renovation $111,658
Human Resources for Health $798,814
Water $123,000
Key Issues Identified in Mechanism
Child Survival Activities
Military Populations
Mobile Populations
Safe Motherhood
Tuberculosis
Workplace Programs